Extendicare Statistics
Extendicare (0S9E) Stock Statistics & Valuation Metrics
Total Valuation
Extendicare has a market cap or net worth of CAD 2.77B. The enterprise value is CAD 3.40B.
- Market Cap
- CAD 2.77B
- Enterprise Value
- CAD 3.40B
Share Statistics
Extendicare has 95,046,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 95,046,400
- Owned by Insiders
- 8.04%
- Owned by Institutions
- 13.74%
Financial Efficiency
Extendicare’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 13.59%.
- Return on Equity (ROE)
- 0.26
- Return on Assets (ROA)
- 0.09
- Return on Invested Capital (ROIC)
- 13.59%
- Return on Capital Employed (ROCE)
- 0.19
- Revenue Per Employee
- 70.66K
- Profits Per Employee
- 4,113.021
- Employee Count
- 23,500
- Asset Turnover
- 1.56
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Extendicare is 20.68. Extendicare’s PEG ratio is 1.00.
- PE Ratio
- 20.68
- PS Ratio
- 1.27
- PB Ratio
- 6.45
- Price to FCF
- 48.95
- Price to Operating Cash Flow
- 19.00
- PEG Ratio
- 1.00
Income Statement
In the last 12 months, Extendicare had revenue of 1.66B and earned 96.66M in profits. Earnings per share was 1.13.
- Revenue
- 1.66B
- Gross Profit
- 199.59M
- Operating Income
- 138.37M
- Pretax Income
- 130.10M
- Net Income
- 96.66M
- EBITDA
- 175.61M
- Earnings Per Share (EPS)
- 1.13
Cash Flow
In the last 12 months, operating cash flow was 145.55M and capital expenditures -89.34M, giving a free cash flow of 56.21M billion.
- Operating Cash Flow
- 145.55M
- Free Cash Flow
- 56.21M
- Free Cash Flow per Share
- 0.59
Dividends & Yields
Extendicare pays an annual dividend of CAD 0.04, resulting in a dividend yield of 1.78%
- Dividend Per Share
- CAD 0.04
- Dividend Yield
- 1.78%
- Payout Ratio
- 40.86%
- Free Cash Flow Yield
- 2.03%
- Earnings Yield
- 4.72%
Stock Price Statistics
- Beta
- -0.04
- 52-Week Price Change
- 47.05%
- 50-Day Moving Average
- 28.76
- 200-Day Moving Average
- 30.29
- Relative Strength Index (RSI)
- 64.98
- Average Volume (3m)
- 164
Important Dates
Extendicare upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- Jul 31, 2026
Financial Position
Extendicare as a current ratio of 1.37, with Debt / Equity ratio of 91.85%
- Current Ratio
- 1.37
- Quick Ratio
- 1.37
- Debt to Market Cap
- 0.18
- Net Debt to EBITDA
- -0.04
- Interest Coverage Ratio
- 7.20
Taxes
In the past 12 months, Extendicare has paid 33.45M in taxes.
- Income Tax
- 33.45M
- Effective Tax Rate
- 0.26
Enterprise Valuation
Extendicare EV to EBITDA ratio is 13.86, with an EV/FCF ratio of 58.44.
- EV to Sales
- 1.52
- EV to EBITDA
- 13.86
- EV to Free Cash Flow
- 58.44
- EV to Operating Cash Flow
- 22.57
Balance Sheet
Extendicare has CAD 75.26M in cash and marketable securities with CAD 590.39M in debt, giving a net cash position of -CAD 515.13M billion.
- Cash & Marketable Securities
- CAD 75.26M
- Total Debt
- CAD 590.39M
- Net Cash
- -CAD 515.13M
- Net Cash Per Share
- -CAD 5.42
- Tangible Book Value Per Share
- -CAD 4.12
Margins
Gross margin is 62.47%, with operating margin of 8.72%, and net profit margin of 6.06%.
- Gross Margin
- 62.47%
- Operating Margin
- 8.72%
- Pretax Margin
- 7.86%
- Net Profit Margin
- 6.06%
- EBITDA Margin
- 10.94%
- EBIT Margin
- 8.48%
Analyst Forecast
The average price target for Extendicare is CAD 40.08, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- CAD 40.08
- Price Target Upside
- 37.32% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 6
- Revenue Growth Forecast
- 36.24%
- EPS Growth Forecast
- 29.85%
Scores
- Smart Score
- 9
- AI Score
- ―

